The sediment of mixtures of charged colloids: segregation and inhomogeneous electric fields

We theoretically study sedimentation-diffusion equilibrium of dilute binary, ternary, and polydisperse mixtures of colloidal particles with different buoyant masses and/or charges. We focus on the low-salt regime, where the entropy of the screening ions drives spontaneous charge separation and the formation of an inhomogeneous macroscopic electric field. The resulting electric force lifts the colloids against gravity, yielding highly nonbarometric and even nonmonotonic colloidal density profiles. The most profound effect is the phenomenon of segregation into layers of colloids with equal mass-per-charge, including the possibility that heavy colloidal species float onto lighter ones

Sedimentation of binary mixtures of like- and oppositely charged colloids: the primitive model or effective pair potentials?

We study sedimentation equilibrium of low-salt suspensions of binary mixtures of charged colloids, both by Monte Carlo simulations of an effective colloids-only system and by Poisson-Boltzmann theory of a colloid-ion mixture. We show that the theoretically predicted lifting and layering effect, which involves the entropy of the screening ions and a spontaneous macroscopic electric field [J. Zwanikken and R. van Roij, Europhys. Lett. {\bf 71}, 480 (2005)], can also be understood on the basis of an effective colloid-only system with pairwise screened-Coulomb interactions. We consider, by theory and by simulation, both repelling like-charged colloids and attracting oppositely charged colloids, and we find a re-entrant lifting and layering phenomenon when the charge ratio of the colloids varies from large positive through zero to large negative values

Dynamics of Binary Mixtures with Ions: Dynamic Structure Factor and Mesophase Formation

Dynamic equations are presented for polar binary mixtures containing ions in the presence of the preferential solvation. In one-phase states, we calculate the dynamic structure factor of the composition accounting for the ion motions. Microphase separation can take place for sufficiently large solvation asymmetry of the cations and the anions. We show two-dimensional simulation results of the mesophase formation with an antagonistic salt, where the cations are hydrophilic and the anions are hydrophobic. The structure factor S(q) in the resultant mesophase has a sharp peak at an intermediate wave number on the order of the Debye-Huckel wave number. As the quench depth is increased, the surface tension nearly vanishes in mesophases due to an electric double layer.Comment: 24 pages, 10 figures, to appear in Journal of Physics: Condensed Matte

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Importance: Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS). Objective: To compare the effectiveness of AHSCT vs fingolimod, natalizumab, and ocrelizumab in relapsing-remitting MS by emulating pairwise trials. Design, Setting, and Participants: This comparative treatment effectiveness study included 6 specialist MS centers with AHSCT programs and international MSBase registry between 2006 and 2021. The study included patients with relapsing-remitting MS treated with AHSCT, fingolimod, natalizumab, or ocrelizumab with 2 or more years study follow-up including 2 or more disability assessments. Patients were matched on a propensity score derived from clinical and demographic characteristics. Exposure: AHSCT vs fingolimod, natalizumab, or ocrelizumab. Main outcomes: Pairwise-censored groups were compared on annualized relapse rates (ARR) and freedom from relapses and 6-month confirmed Expanded Disability Status Scale (EDSS) score worsening and improvement. Results: Of 4915 individuals, 167 were treated with AHSCT; 2558, fingolimod; 1490, natalizumab; and 700, ocrelizumab. The prematch AHSCT cohort was younger and with greater disability than the fingolimod, natalizumab, and ocrelizumab cohorts; the matched groups were closely aligned. The proportion of women ranged from 65% to 70%, and the mean (SD) age ranged from 35.3 (9.4) to 37.1 (10.6) years. The mean (SD) disease duration ranged from 7.9 (5.6) to 8.7 (5.4) years, EDSS score ranged from 3.5 (1.6) to 3.9 (1.9), and frequency of relapses ranged from 0.77 (0.94) to 0.86 (0.89) in the preceding year. Compared with the fingolimod group (769 [30.0%]), AHSCT (144 [86.2%]) was associated with fewer relapses (ARR: mean [SD], 0.09 [0.30] vs 0.20 [0.44]), similar risk of disability worsening (hazard ratio [HR], 1.70; 95% CI, 0.91-3.17), and higher chance of disability improvement (HR, 2.70; 95% CI, 1.71-4.26) over 5 years. Compared with natalizumab (730 [49.0%]), AHSCT (146 [87.4%]) was associated with marginally lower ARR (mean [SD], 0.08 [0.31] vs 0.10 [0.34]), similar risk of disability worsening (HR, 1.06; 95% CI, 0.54-2.09), and higher chance of disability improvement (HR, 2.68; 95% CI, 1.72-4.18) over 5 years. AHSCT (110 [65.9%]) and ocrelizumab (343 [49.0%]) were associated with similar ARR (mean [SD], 0.09 [0.34] vs 0.06 [0.32]), disability worsening (HR, 1.77; 95% CI, 0.61-5.08), and disability improvement (HR, 1.37; 95% CI, 0.66-2.82) over 3 years. AHSCT-related mortality occurred in 1 of 159 patients (0.6%). Conclusion: In this study, the association of AHSCT with preventing relapses and facilitating recovery from disability was considerably superior to fingolimod and marginally superior to natalizumab. This study did not find evidence for difference in the effectiveness of AHSCT and ocrelizumab over a shorter available follow-up time

Strategies for improving the performance of planning: some empirical research

In this paper we accept the performance problem as given, including the theoretical analysis of it made elsewhere. Here we report empirical research into whether people making strategic plans were aware of this performance problem and, if so, what they did to improve the performance of their plans. Six strategic plans made by provinces and four made by larger municipalities were investigated. The plan-makers wanted their plans to fulfill various functions and chose methods of plan-making, including the plan content, so as to increase the probability that the functions would indeed be fulfilled. The strategies followed were varied and differed according to the function. A plan which fulfills a function is performance, under another name. What plan-makers need is guidance about how to make strategic plans that will perform more efficiently. This could be derived from a combination of ex ante and ex post evaluation of performance.